{"id":"https://openalex.org/W4402449983","doi":"https://doi.org/10.3390/pharmaceutics16091194","title":"Powder Self-Emulsifying Drug Delivery System for Mitotane: In Vitro and In Vivo Evaluation","display_name":"Powder Self-Emulsifying Drug Delivery System for Mitotane: In Vitro and In Vivo Evaluation","alternate_titles":[],"publication_year":2024,"publication_date":"2024-09-11","ids":{"openalex":"https://openalex.org/W4402449983","doi":"https://doi.org/10.3390/pharmaceutics16091194","pmid":"https://pubmed.ncbi.nlm.nih.gov/39339230","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11434810"},"language":"en","primary_location":{"id":"doi:10.3390/pharmaceutics16091194","doi":"https://doi.org/10.3390/pharmaceutics16091194","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics16091194","pdf_url":"https://www.mdpi.com/1999-4923/16/9/1194/pdf?version=1726045478","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4402449983"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/1999-4923/16/9/1194/pdf?version=1726045478","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008536585","display_name":"Mohamed Skiba","orcid":"https://orcid.org/0000-0002-0360-7743","observed_orcids":["https://orcid.org/0000-0002-0360-7743"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Mohamed Skiba","raw_affiliation_strings":["Normandie Univ., UNIROUEN, INSERM, NORDIC UMR 1239, F-76000 Rouen, France"],"raw_orcid":"https://orcid.org/0000-0002-0360-7743","affiliations":[{"raw_affiliation_string":"Normandie Univ., UNIROUEN, INSERM, NORDIC UMR 1239, F-76000 Rouen, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107130685","display_name":"Valentin Lef\u00e9bure","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Valentin Lef\u00e9bure","raw_affiliation_strings":["Normandie Univ., UNIROUEN, INSERM, NORDIC UMR 1239, F-76000 Rouen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Normandie Univ., UNIROUEN, INSERM, NORDIC UMR 1239, F-76000 Rouen, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076354128","display_name":"Fr\u00e9deric Bounoure","orcid":"https://orcid.org/0000-0002-7352-3043","observed_orcids":["https://orcid.org/0000-0002-7352-3043"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Frederic Bounoure","raw_affiliation_strings":["Normandie Univ., UNIROUEN, INSERM, NORDIC UMR 1239, F-76000 Rouen, France"],"raw_orcid":"https://orcid.org/0000-0002-7352-3043","affiliations":[{"raw_affiliation_string":"Normandie Univ., UNIROUEN, INSERM, NORDIC UMR 1239, F-76000 Rouen, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103828790","display_name":"Nicolas Milon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nicolas Milon","raw_affiliation_strings":["Normandie Univ., UNIROUEN, INSERM, NORDIC UMR 1239, F-76000 Rouen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Normandie Univ., UNIROUEN, INSERM, NORDIC UMR 1239, F-76000 Rouen, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013804417","display_name":"Micha\u00ebl Thomas","orcid":"https://orcid.org/0000-0003-2901-824X","observed_orcids":["https://orcid.org/0000-0003-2901-824X"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Michael Thomas","raw_affiliation_strings":["Normandie Univ., UNIROUEN, INSERM, NORDIC UMR 1239, F-76000 Rouen, France"],"raw_orcid":"https://orcid.org/0000-0003-2901-824X","affiliations":[{"raw_affiliation_string":"Normandie Univ., UNIROUEN, INSERM, NORDIC UMR 1239, F-76000 Rouen, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040128812","display_name":"Herv\u00e9 Lef\u00e8bvre","orcid":"https://orcid.org/0000-0002-6181-9648","observed_orcids":["https://orcid.org/0000-0002-6181-9648"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Herve Lefebvre","raw_affiliation_strings":["Normandie Univ., UNIROUEN, INSERM, NORDIC UMR 1239, F-76000 Rouen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Normandie Univ., UNIROUEN, INSERM, NORDIC UMR 1239, F-76000 Rouen, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060848661","display_name":"Malika Lahiani\u2010Skiba","orcid":"https://orcid.org/0000-0002-1774-866X","observed_orcids":["https://orcid.org/0000-0002-1774-866X"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Lahiani-Skiba Malika","raw_affiliation_strings":["Normandie Univ., UNIROUEN, INSERM, NORDIC UMR 1239, F-76000 Rouen, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Normandie Univ., UNIROUEN, INSERM, NORDIC UMR 1239, F-76000 Rouen, France","institution_ids":["https://openalex.org/I154526488"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5008536585"],"corresponding_institution_ids":["https://openalex.org/I154526488"],"apc_list":{"value":2900,"currency":"CHF","value_usd":3296},"apc_paid":{"value":2900,"currency":"CHF","value_usd":3296},"fwci":0.8485,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.62746444,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":97},"biblio":{"volume":"16","issue":"9","first_page":"1194","last_page":"1194"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10411","display_name":"Proteins in Food Systems","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1106","display_name":"Food Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mitotane","display_name":"mitotane","score":0.9890000224113464},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.8730000257492065},{"id":"https://openalex.org/keywords/poorly-water-soluble-drugs","display_name":"poorly water-soluble drugs","score":0.8930000066757202},{"id":"https://openalex.org/keywords/alpha-cyclodextrin","display_name":"\u03b1-cyclodextrin","score":0.8289999961853027},{"id":"https://openalex.org/keywords/adrenocortical-carcinoma","display_name":"adrenocortical carcinoma","score":0.8399999737739563},{"id":"https://openalex.org/keywords/cushing-s-syndrome","display_name":"Cushing's syndrome","score":0.9390000104904175},{"id":"https://openalex.org/keywords/dissolution-rate","display_name":"dissolution rate","score":0.7490000128746033},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9559999704360962},{"id":"https://openalex.org/keywords/first-pass-metabolism","display_name":"first-pass metabolism","score":0.7559999823570251}],"concepts":[{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.9583102464675903},{"id":"https://openalex.org/C2776735609","wikidata":"https://www.wikidata.org/wiki/Q417465","display_name":"Mitotane","level":3,"score":0.895740270614624},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6675562858581543},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.6638549566268921},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.648677408695221},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5998132228851318},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5965387225151062},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.556690514087677},{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.5503725409507751},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2773357331752777},{"id":"https://openalex.org/C2781399356","wikidata":"https://www.wikidata.org/wiki/Q918285","display_name":"Adrenocortical carcinoma","level":2,"score":0.1898878812789917},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14196226000785828},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.12374916672706604},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.06831243634223938},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3390/pharmaceutics16091194","doi":"https://doi.org/10.3390/pharmaceutics16091194","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics16091194","pdf_url":"https://www.mdpi.com/1999-4923/16/9/1194/pdf?version=1726045478","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11434810","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11434810","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11434810/pdf/pharmaceutics-16-01194.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"Text"},{"id":"pmid:39339230","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39339230","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-04911221v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/hal-04911221v1/document","pdf_url":"https://hal.science/hal-04911221/document","source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceutics, 2024, 16 (9), pp.1194. &#x27E8;10.3390/pharmaceutics16091194&#x27E9;","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:a034cde9cb2947478ad9bad2c1b047b0","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/a034cde9cb2947478ad9bad2c1b047b0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceutics, Vol 16, Iss 9, p 1194 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3390/pharmaceutics16091194","doi":"https://doi.org/10.3390/pharmaceutics16091194","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics16091194","pdf_url":"https://www.mdpi.com/1999-4923/16/9/1194/pdf?version=1726045478","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4402449983.pdf","grobid_xml":"https://content.openalex.org/works/W4402449983.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W99169869","https://openalex.org/W233036222","https://openalex.org/W1481956726","https://openalex.org/W1910274646","https://openalex.org/W1969237887","https://openalex.org/W1974493478","https://openalex.org/W1977072597","https://openalex.org/W1980535921","https://openalex.org/W1987174700","https://openalex.org/W2018222606","https://openalex.org/W2060320802","https://openalex.org/W2067642308","https://openalex.org/W2068845486","https://openalex.org/W2070227029","https://openalex.org/W2079141522","https://openalex.org/W2095615409","https://openalex.org/W2101248051","https://openalex.org/W2105695548","https://openalex.org/W2114699004","https://openalex.org/W2115439624","https://openalex.org/W2123110539","https://openalex.org/W2130421223","https://openalex.org/W2147573461","https://openalex.org/W2156483611","https://openalex.org/W2253332708","https://openalex.org/W2579205338","https://openalex.org/W2599001013","https://openalex.org/W2793126280","https://openalex.org/W3021600979","https://openalex.org/W3116126943","https://openalex.org/W3186357112","https://openalex.org/W4211233876","https://openalex.org/W4292166992"],"related_works":["https://openalex.org/W2070227029","https://openalex.org/W2076298990","https://openalex.org/W2043810138","https://openalex.org/W2009256112","https://openalex.org/W7084752067","https://openalex.org/W1620184170","https://openalex.org/W7216527471","https://openalex.org/W2184465986","https://openalex.org/W2022870730","https://openalex.org/W3019279729"],"abstract_inverted_index":{"Drug":[0],"Delivery":[1],"Systems":[2],"(DDSs)":[3],"of":[4,16,38,48,69,92,134,166,182,232],"known":[5],"drugs":[6],"are":[7],"prominent":[8],"candidates":[9],"for":[10,35,78,146,225],"new":[11,71,90],"and":[12,27,105,116,129,138,149,179,199,222,230],"more":[13],"effective":[14,223],"treatments":[15],"various":[17],"diseases,":[18],"as":[19],"they":[20],"may":[21],"increase":[22],"drug":[23,74],"solubility,":[24],"dissolution":[25,177,228],"velocity,":[26],"bioavailability.":[28,84],"Mitotane":[29],"(o,p\u2032-dichlorodimethyl":[30],"dichloroethane":[31],"[o,p\u2032-DDD])":[32],"is":[33,50],"used":[34],"the":[36,46,67,89,98,132,164,171,175,183,212,215,227],"treatment":[37],"adrenocortical":[39],"cancer":[40],"and,":[41],"occasionally,":[42],"Cushing\u2019s":[43],"syndrome.":[44],"However,":[45],"efficacy":[47],"mitotane":[49,79,167,206],"limited":[51,103],"by":[52,58],"its":[53,59,82,102,110,150],"low":[54],"oral":[55,83],"bioavailability,":[56],"caused":[57],"extremely":[60],"poor":[61],"aqueous":[62],"solubility.":[63],"This":[64],"research":[65],"explores":[66],"development":[68],"a":[70,93,136,160,191,220],"powder":[72],"self-emulsifying":[73],"delivery":[75],"system":[76],"(P-SEDDS)":[77],"to":[80,96,174,211],"improve":[81],"The":[85,120,141,157,187],"study":[86],"focuses":[87],"on":[88],"concept":[91],"mitotane-loaded":[94,192],"P-SEDDS":[95,121,193,216],"overcome":[97],"challenges":[99],"associated":[100],"with":[101,131,204],"solubility":[104],"high":[106],"logP,":[107],"thereby":[108],"improving":[109,226],"therapeutic":[111],"efficacy,":[112],"reducing":[113],"off-target":[114],"toxicity,":[115],"avoiding":[117],"first-pass":[118],"metabolism.":[119],"formulations":[122,207],"were":[123],"meticulously":[124],"designed":[125],"using":[126],"only":[127],"\u03b1-cyclodextrin":[128],"oil,":[130],"goal":[133],"achieving":[135],"stable":[137],"efficient":[139],"P-SEDDS.":[140],"optimized":[142],"formulation":[143,217],"was":[144,153],"characterized":[145],"pharmaceutical":[147],"properties,":[148],"pharmacokinetic":[151],"behavior":[152],"examined":[154],"in":[155,163,197,200],"rats.":[156],"results":[158,188],"demonstrated":[159],"significant":[161],"enhancement":[162],"bioavailability":[165,231],"when":[168],"delivered":[169],"through":[170],"P-SEDDS,":[172],"attributed":[173],"increased":[176],"velocity":[178],"improved":[180],"absorption":[181],"poorly":[184,233],"water-soluble":[185],"drug.":[186],"suggest":[189],"that":[190,214],"has":[194],"distinctly":[195],"enhanced":[196],"vitro":[198],"vivo":[201],"performance":[202],"compared":[203],"conventional":[205],"(Lysodren\u00ae),":[208],"which":[209],"leads":[210],"conclusion":[213],"could":[218],"be":[219],"viable":[221],"strategy":[224],"rate":[229],"aqueous-soluble":[234],"ingredients.":[235]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4402449983","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2024-09-12T00:00:00"}
